In the BioHarmony Drug Report Database
Cilostazol
Pletal (cilostazol) is a small molecule pharmaceutical. Cilostazol was first approved as Pletal on 1999-01-15. It is used to treat intermittent claudication, peripheral vascular diseases, and vascular graft occlusion in the USA. The pharmaceutical is active against cGMP-inhibited 3′,5′-cyclic phosphodiesterase B. In addition, it is known to target cGMP-inhibited 3′,5′-cyclic phosphodiesterase A.
Trade Name
|
Pletal |
|---|---|
Common Name
|
cilostazol |
ChEMBL ID
|
CHEMBL799 |
Indication
|
intermittent claudication, peripheral vascular diseases, vascular graft occlusion |
Drug Class
|
Image (chem structure or protein)